| 翻訳と辞書 |
| Peter Besler ： ウィキペディア英語版 |
Peter Besler
Peter Besler (born October 5, 1963) is an investment advisor and author residing in Toronto, Ontario, Canada. Born in Waterloo, Ontario, Besler is known for raising public funds in order to finance Canadian companies conducting research into the treatment of serious and terminal illnesses. Since 1986, his efforts have benefited numerous biotechnology and medical research companies conducting pre-clinical and phase I, II, and III human clinical trials.〔Vasogen Inc., http://www.intellipharmaceutics.com/history.cfm, BioMS Medical Inc. http://www.medwellcapital.com/, Protox Therapeutics http://www.protoxtherapeutics.com/about-overview.php, Hemosol Biopharma Inc. http://www.therapurebio.com/PageContent/Default.aspx?SectionID=2&SectionHeadlineID=3〕
== Biography ==
Besler was as a co-op chemistry student at University of Waterloo. In 1982, he grew concerned that scientific research in Canada was inadequately funded.〔Federal Scientific Activities, Copyright Statistics Canada Ministry of Industry, ref. National Research Council (Canada), Catalogue No. 88-204-XPB ISSN 0824-0310 1988〕 He co-led the Progressive Conservative Party Campus Youth in 1983.〔University of Waterloo Alumni Directory, Second Edition 1990, Office of Alumni Affairs pg. 1:31〕 Switching his area of study, he graduated with a degree in Economics in 1986. Shortly after graduation, he moved to Toronto and studied investment banking under Gerszon Taichman.〔Bank of America Merrill Lynch Canada http://gmi.ml.com/ca/〕 In 1994, Besler traveled to China with the purpose of establishing in-vitro fertilization clinics with researchers from Cornell University.〔The Center For Reproductive Medicine and Infertility (CRMI) http://www.ivf.org, Dr. Kangpu Xu, JAMA 281: 1701-1706〕 In 2001, he became aware of promising research conducted by Dr. Ingrid Katz into a treatment for multiple sclerosis at the University of Edmonton. In 2003, he was instrumental in obtaining the financing required to receive Health Canada approval for advancing this research through phase II human clinical trials.〔Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta, Canada Multiple Sclerosis, Vol. 14, No. 7, 872-879 (2008) 〕 The trials received FDA fast track approval in 2008.〔http://clinicaltrials.gov, "A Study for Patients With Relapsing Remitting Multiple Sclerosis (MINDSET01)" Eli Lilly and Company, Trial Identifier NCT00869986〕
Besler is involved in philanthropic and volunteer work for several Canadian charitable organizations.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Peter Besler」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|